Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety, PK and PD of AZD7594 in Healthy Japanese Men
NCT02645253Phase 1Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2016
- Primary completion
- Apr 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of velsecorat in asthma and chronic obstructive pulmonary disease (COPD) (4 cohorts), sponsored by AstraZeneca. Primary endpoint: Number of Participants With Adverse Events. Started Jan 2016; status: completed.
02
Drugs
velsecorat
03
Conditions
asthmachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02645253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02645253.